content s iii - thieme · content s iii phar macops ychiatr y 2007; 40 issue 1 (january 2007) =...
TRANSCRIPT
![Page 1: Content s III - Thieme · Content s III Phar macops ychiatr y 2007; 40 Issue 1 (January 2007) = Page 1 – 45 Issue 2 (March 2007) = Page 47 – 87](https://reader035.vdocuments.us/reader035/viewer/2022071101/5fdae29ed6608009004e5f82/html5/thumbnails/1.jpg)
![Page 2: Content s III - Thieme · Content s III Phar macops ychiatr y 2007; 40 Issue 1 (January 2007) = Page 1 – 45 Issue 2 (March 2007) = Page 47 – 87](https://reader035.vdocuments.us/reader035/viewer/2022071101/5fdae29ed6608009004e5f82/html5/thumbnails/2.jpg)
![Page 3: Content s III - Thieme · Content s III Phar macops ychiatr y 2007; 40 Issue 1 (January 2007) = Page 1 – 45 Issue 2 (March 2007) = Page 47 – 87](https://reader035.vdocuments.us/reader035/viewer/2022071101/5fdae29ed6608009004e5f82/html5/thumbnails/3.jpg)
Contents III
Pharmacopsychiatry 2007; 40
Issue 1 (January 2007) = Page 1 – 45 Issue 2 (March 2007) = Page 47 – 87 Issue 3 (May 2007) = Page 89 – 133 Issue 4 (July 2007) = Page 135 – 171 Issue 5 (September 2007) = Page 173 – 204 Issue 6 (November 2007) = Page 257 – 296 Issue S 1 (December 2007) = Page S1 – S92
Editorials
S1 Tretter, F., W.E. MüllerEditorial
Letters
128 Bachmann, C., J. Grabarkiewicz, F.M. Theisen,H. RemschmidtIsotretinoin, Depression and Suicide Ideation in an Ado-lescent Boy
169 Baldaçara, L., M.C. de Castro Ferrari, B.F. Monteiro,R.R. Uchida, M. SanchesHypomania Induced by Atypical Antipsychotics amongSchizophrenic Patients: Report of Three Cases
292 Biermann, T., S. Bleich, J. Kornhuber, T. HillemacherPregabalin in Benzodiazepine Withdrawal
294 Blaschke, D., A.S. Parwani, M. Huemer, S. Rolf, L-H. Boldt, R. Dietz, W. HaverkampTorsade de Pointes during Combined Treatment withRisperidone and Citalopram
41 de Toledo Ferraz Alves, T.C., A. Guerra de AndradeHypertension Induced by Regular Doses of Milnacipran:A Case Report
38 Domula, M., D. Schulze, W. Felber, J. Gallinat, U.E. LangCat Eye Syndrome Associated with Schizophrenia
289 Ghanizadeh, A.Sertraline and Tic: Case Report
287 Greiner, C., M. Wittmann, E. HaenLamotrigine Serum Concentrations under ValproateComedication: “Contraindication” or “Safe Combina-tion”?
44 Haberfellner, E.M.Priapism with Sertraline-Risperidone Combination
132 Habermeyer, B., P. FuhrAuthors' Reply
87 Habermeyer, B., P. FuhrAuthors' Reply Obessive-compulsive Disorders Due toNeuroacanthocytosis Treated with Citalopram
83 Hung, Galen.Chin-Lun., Ying-Yeh. ChenExtrapyramidal Side Effects Associated with Aripipra-zole Administration in a Schizophrenic Patient
129 Jagsch, C., J. Marksteiner, E. Seiringer, E. WindhagerSuccessful Mirtazapine Treatment of an 81-Year-oldPatient With Syndrome of Inappropriate AntidiureticHormone Secretion
129 Jakob, F., J. WolfEPMS Under Antidepressive Therapy With Fluvoxamineand Concomitant Antibiotic Therapy With Clindamycin
41 Kellner, M.Aripiprazole in a Therapy-resistant Patient with Border-line Personality and Post-Traumatic Stress Disorder
85 Khazaal, Y., D.F. ZullinoRebound of Weight Gain Following Topiramate Cessa-tion
82 Koethe, D., T. Dietl, F.M. Leweke, E. FriessCessation of Complex Visual Hallucinations duringTreatment with Mirtazapine
86 Lange-Asschenfeldt, C., I. Blaeser, T. SupprianBipolar Switching after Carbamazepine Withdrawal
170 Neuhaus, A.H., A. Luborzewski, C. Opgen-Rhein,M.C. Jockers-Scherübl, P. NeuElectroconvulsive Monotherapy in Confusion Psychosis:A Potential Standard Regimen?
295 Oulis, P., G.C. Koulouris, G. Konstantakopoulos,V.G. MasdrakisMarked Elevation of Creatine Kinase with Sertindole: ACase Report
203 Plesnicar, B.K., J.K. Lasic, A. PlesnicarQuetiapine and Elevated Creatine Phosphokinase (CK)
291 Soyka, M., B. Täschner, N. ClausiusNeuroleptic Treatment of Alcohol Hallucinosis: CaseSeries
39 Sperling, W., J. Kornhuber, J. Wiltfang, S. BleichCombined VNS - rTMS Treatment in a Patient withTherapy Resistant Depression
201 Takahashi, M., E. Sawayama, T. Sawayama, H. MiyaokaReversible Paroxetine-Induced Symptomatic Hypothy-roidism
37 Traber, R., R. Schneiter, J. ModestinA Case of Aripiprazole-induced Mania
43 Victorri-Vigneau, C., M. Guerlais, P. JollietAbuse, Dependency and Withdrawal with Gabapentin:A First Case Report
199 Wakeno, M., G. Okugawa, Y. Takekita, M. Kato,T. Fukuda, M. Yamashita, Y. Hosoi, J. Azuma, T. KinoshitaDelirium Associated with Paroxetine in an ElderlyDepressive Patient: A Case Report
132 Walker, R.H., A. DanekObsessive-compulsive Disorders Due to Neuroacantho-cytosis Treated with Citalopram
84 Yoshida, K., H. Higuchi, N. OzakiSuccessful Treatment of Severe Antidepressant-InducedNausea with a Combination of Milnacipran and Olanza-pine
202 Zink, M., S. Englisch, U. Knopf, A. Kuwilsky, H. DressingAugmentation of Clozapine with Valproic Acid forClozapine-Induced Obsessive-Compulsive Symptoms
Original Papers
30 Assion, H.J., C. JungckOff-label Prescribing in a German Psychiatric Hospital
152 Bandelow, B., D.J. Stein, O.T. Dolberg, H.F. Andersen,D.S. BaldwinImprovement of Quality of Life in Panic Disorder withEscitalopram, Citalopram, or Placebo
163 Bech, P.Dose-response Relationship of Pregabalin in Patientswith Generalized Anxiety Disorder. A Pooled Analysis ofFour Placebo-controlled Trials
68 Calandre, E.P., P. Morillas-Arques, C.M. Rodriguez-Lopez,F. Rico-Villademoros, J. HidalgoPregabalin Augmentation of Quetiapine Therapy in theTreatment of Fibromyalgia: An Open-Label, ProspectiveTrial
107 Castberg, I., O. SpigsetEffects of Comedication on the Serum Levels of Arip-iprazole: Evidence from a Routine Therapeutic DrugMonitoring Service
58 Cohen, S., K-U. Kühn, S. Bender, A. Erfurth, M. Gastpar,A. Murafi, M. Rothermundt, J. Signerski, B. Sträter,L. Teusch, W. Weig, A. Welling, J. Westheide, T.J. HuberSexual Impairment in Psychiatric Inpatients: Focus onDepression
![Page 4: Content s III - Thieme · Content s III Phar macops ychiatr y 2007; 40 Issue 1 (January 2007) = Page 1 – 45 Issue 2 (March 2007) = Page 47 – 87](https://reader035.vdocuments.us/reader035/viewer/2022071101/5fdae29ed6608009004e5f82/html5/thumbnails/4.jpg)
IV Contents
Pharmacopsychiatry 2007; 40
264 de Haan, L., T. van Amelsvoort, P. Dingemans, D. LinszenRisk Factors for Medication Non-Adherence in Patientswith First Episode Schizophrenia and Related Disor-ders; A Prospective Five Year Follow-Up
146 Drozdz, W., A. Borkowska, M. Wilkosc, W. Halota,D. Dybowska, J.K. RybakowskiChronic Paranoid Psychosis and Dementia FollowingInterferon-α Treatment of Hepatitis C: A Case Report
275 Gallhofer, B., P. Jaanson, A. Mittoux, P. Tanghøj, S. Lis,S. KriegerCourse of Recovery of Cognitive Impairment in Patientswith Schizophrenia: A Randomised Double-blind StudyComparing Sertindole and Haloperidol
191 Gallinat, J., D.J. Müller, J. Bierbrauer, H. Rommelspacher,G. Juckel, C. WernickeFunctional Cortical Effects of Novel Allelic Variants ofthe Serotonin Transporter Gene-linked PolymorphicRegion (5-HTTLPR) in Humans
64 Gallinat, J., F. SchubertRegional Cerebral Glutamate Concentrations andChronic Tobacco Consumption
S40 Gallinat, J., K. Obermayer, A. HeinzSystems Neurobiology of the Dysfunctional Brain:Schizophrenia
72 Gerlach, M., R. Hünnerkopf, S. Rothenhöfer, G. Libal,R. Burger, H-W. Clement, J.M. Fegert, Ch. Wewetzer,C. Mehler-WexTherapeutic Drug Monitoring of Quetiapine in Adoles-cents with Psychotic Disorders
25 Goedhard, L.E., J.J. Stolker, H.L. Nijman, A.C. Egberts,E.R. HeerdinkAggression of Psychiatric Patients Associated with theUse of As-needed Medication
S54 Haenschel, C., P.J. Uhlhaas, W. SingerSynchronous Oscillatory Activity and Working Memoryin Schizophrenia
1 Hofer, A., M.A. Rettenbacher, M. Edlinger, R. Huber,T. Bodner, G. Kemmler, G. Sachs, W.W. FleischhackerOutcomes in Schizophrenia Outpatients Treated withAmisulpride or Olanzapine
196 Kirsch, P., S. Ronshausen, D. Mier, B. GallhoferThe Influence of Antipsychotic Treatment on BrainReward System Reactivity in Schizophrenia Patients
S34 Koch, M.On the Effects of Partial Agonists of Dopamine Recep-tors for the Treatment of Schizophrenia
93 Leon, Jde., M.T. Susce, R-M. Pan, P.J. Wedlund,M.L. Orrego, F.J. DiazA Study of Genetic (CYP2D6 and ABCB1) and Environ-mental (Drug Inhibitors and Inducers) Variables ThatMay Influence Plasma Risperidone Levels
S17 Leuner, K., W.E. MüllerDopamine in the Prefrontal Cortex and its DifferentModulation by Conventional and Atypical Antipsy-chotics
77 Linden, M., K. SchotteA Randomized Controlled Clinical Trial Comparing“Guideline Exposed” and “Guideline Naive” Physiciansin Respect to Dosage Selection and Treatment Outcomewith Doxepin in Depressive Disorders
S78 Loh, M., E.T. Rolls, G. DecoStatistical Fluctuations in Attractor Networks Related toSchizophrenia
14 López-Muñoz, F., C. Álamo, G. Rubio, P. García-García,A. PardoReboxetine Combination in Treatment-resistantDepression to Selective Serotonin Reuptake Inhibitors
257 Marinis, T.De., P.T. Saleem, P. Glue, W.J. Arnoldussen,R. Teijeiro, A. Lex, M.A. Latif, R. MedoriSwitching to Long-Acting Injectable Risperidone is Ben-eficial with Regard to Clinical Outcomes, Regardlessof Previous Conventional Medication in Patients withSchizophrenia
116 Martin-Latry, K., C. Ricard, H. VerdouxA One-Day Survey of Characteristics of Off-Label Hospi-tal Prescription of Psychotropic Drugs
89 Mauri, M.C., A. Colasanti, M. Rossattini, L.S. Volonteri,F. Dragogna, A. Fiorentini, A. Valli, P. PapaZiprasidone Outcome and Tolerability: A Practical Clini-cal Trial With Plasma Drug Levels
S62 Meisenzahl, E.M., J. Scheuerecker, G.J. Schmitt,H.J. MöllerDopamine, Prefrontal Cortex and Working MemoryFunctioning in Schizophrenia
135 Molina, V., S. Reig, J. Sanz, T. Palomo, C. Benito,J. Sánchez, J. Pascau, M. DescoChanges in Cortical Volume with Olanzapine in ChronicSchizophrenia
157 Molina, V., J. Sanz, F. Sarramea, T. PalomoMarked Hypofrontality in Clozapine-responsivePatients
53 Möller, H-J., S. Langer, M. SchmaußEscitalopram in Clinical Practice: Results of an Open-Label Trial in Outpatients with Depression in a Natural-istic Setting in Germany
S27 Pietro, N.C., J.K. SeamansDopamine and Serotonin Interactions in the PrefrontalCortex: Insights on Antipsychotic Drugs and TheirMechanism of Action
20 Pjrek, E., D. Winkler, J. Stastny, N. Praschak-Rieder,M. Willeit, S. KasperEscitalopram in Seasonal Affective Disorder: Results ofan Open Trial
103 Rashid, J., R. Wang, S.L. RamerAtypical Antipsychotics and Seborrheic Dermatitis:Three Case Reports
149 Schaefer, M., K. Leopold, A. Hinzpeter, A. Heinz,M. KrebsMemantine-associated Reversal of Clozapine-inducedWeight Gain
S85 Schlösser, R.G., K. Koch, G. WagnerAssessing the State Space of the Brain with fMRI: AnIntegrative View of Current Methods
111 Stolk, P., P.C. Souverein, H.G. Leufkens, J.G. Weil,A.C. Egberts, E.R. HeerdinkThe Association between Exposure to COX-2 Inhibitorsand Schizophrenia Deterioration. A Nested Case-ControlStudy
S2 Tretter, F., M. Albus“Computational Neuropsychiatry” of Working MemoryDisorders in Schizophrenia: The Network Connectivityin Prefrontal Cortex - Data and Models
121 Ulrich, S., C. Hiemke, G. Laux, B. Müller-Oerlinghausen,U. Havemann-Reinecke, P. Riederer, G. Zernig,P. BaumannValue and Actuality of the Prescription Information forTherapeutic Drug Monitoring of Psychopharmaceuti-cals: A Comparison with the Medico-Scientific Evidence
S73 Vogels, T.P., L.F. AbbottGating Deficits in Model Networks: A Path toSchizophrenia?
![Page 5: Content s III - Thieme · Content s III Phar macops ychiatr y 2007; 40 Issue 1 (January 2007) = Page 1 – 45 Issue 2 (March 2007) = Page 47 – 87](https://reader035.vdocuments.us/reader035/viewer/2022071101/5fdae29ed6608009004e5f82/html5/thumbnails/5.jpg)
Contents V
Pharmacopsychiatry 2007; 40
140 Westheide, J., S. Cohen, S. Bender, D. Cooper-Mahkorn,A. Erfurth, M. Gastpar, T.J. Huber, W. Maier, A. Murafi,M. Rothermund, J. Signerski, B. Sträter, L. Teusch,W. Weig, A. Welling, K-U. KühnSexual Dysfunction in Psychiatric Inpatients The Role ofAntipsychotic Medication
183 Westheide, J., C. Helmstaedter, C. Elger, D. Cooper-Mahkorn, B. Sträter, W. Maier, K.U. KühnSexuality in Male Psychiatric Inpatients. A Descrip-tive Comparison of Psychiatric Patients, Patients withEpilepsy and Healthy Volunteers
S45 Winterer, G.Prefrontal Dopamine Signaling in Schizophrenia - TheCorticocentric Model
47 Xiang, Y-T., Y-Z. Weng, C-M. Leung, W-K. Tang,G.S. UngvariClinical and Social Determinants of AntipsychoticPolypharmacy for Chinese Patients with Schizophrenia
269 Xiang, Y-T., Y-Z. Weng, C-M. Leung, W-K. Tang,G.S. UngvariClinical and Social Determinants of Long-Term Use ofBenzodiazepines and its Impact on Quality of Life ofChinese Schizophrenia Patients
9 Yoshimura, R., K. Shinkai, N. Ueda, J. NakamuraValproic Acid improves Psychotic Agitation withoutInfluencing Plasma Risperidone Levels in SchizophrenicPatients
Reviews
173 Haberfellner, E.M.A Review of the Assessment of Antidepressant-InducedSexual Dysfunction used In Randomized, ControlledClinical Trials
![Page 6: Content s III - Thieme · Content s III Phar macops ychiatr y 2007; 40 Issue 1 (January 2007) = Page 1 – 45 Issue 2 (March 2007) = Page 47 – 87](https://reader035.vdocuments.us/reader035/viewer/2022071101/5fdae29ed6608009004e5f82/html5/thumbnails/6.jpg)
VI Authors' Index
Pharmacopsychiatry 2007; 40
A
Abbott, L.F. S73Álamo, C. 14Albus, M. S2Andersen, H.F. 152Arnoldussen, W.J. 257Assion, H.J. 30Azuma, J. 199
B
Bachmann, C. 128Baldaçara, L. 169Baldwin, D.S. 152Bandelow, B. 152Baumann, P. 121Bech, P. 163Bender, S. 58, 140Benito, C. 135Bierbrauer, J. 191Biermann, T. 292Blaeser, I. 86Blaschke, D. 294Bleich, S. 39, 292Bodner, T. 1Boldt, L-H. 294Borkowska, A. 146Burger, R. 72
C
Calandre, E.P. 68Castberg, I. 107Chen, Ying-Yeh. 83Clausius, N. 291Clement, H-W. 72Cohen, S. 58, 140Colasanti, A. 89Cooper-Mahkorn, D. 140, 183
D
Danek, A. 132de Castro Ferrari, M.C. 169Deco, G. S78de Haan, L. 264Desco, M. 135de Toledo Ferraz Alves, T.C. 41Diaz, F.J. 93Dietl, T. 82Dietz, R. 294Dingemans, P. 264Dolberg, O.T. 152Domula, M. 38Dragogna, F. 89Dressing, H. 202Drozdz, W. 146Dybowska, D. 146
E
Edlinger, M. 1Egberts, A.C. 25, 111Elger, C. 183Englisch, S. 202
Erfurth, A. 58, 140
F
Fegert, J.M. 72Felber, W. 38Fiorentini, A. 89Fleischhacker, W.W. 1Friess, E. 82Fuhr, P. 87, 132Fukuda, T. 199
G
Gallhofer, B. 196, 275Gallinat, J. 38, 64, 191, S40García-García, P. 14Gastpar, M. 58, 140Gerlach, M. 72Ghanizadeh, A. 289Glue, P. 257Goedhard, L.E. 25Grabarkiewicz, J. 128Greiner, C. 287Guerlais, M. 43Guerra de Andrade, A. 41
H
Haberfellner, E.M. 44, 173Habermeyer, B. 87, 132Haen, E. 287Haenschel, C. S54Halota, W. 146Havemann-Reinecke, U. 121Haverkamp, W. 294Heerdink, E.R. 25, 111Heinz, A. 149, S40Helmstaedter, C. 183Hidalgo, J. 68Hiemke, C. 121Higuchi, H. 84Hillemacher, T. 292Hinzpeter, A. 149Hofer, A. 1Hosoi, Y. 199Huber, R. 1Huber, T.J. 58, 140Huemer, M. 294Hung, Galen.Chin-Lun. 83Hünnerkopf, R. 72
J
Jaanson, P. 275Jagsch, C. 129Jakob, F. 129Jockers-Scherübl, M.C. 170Jolliet, P. 43Juckel, G. 191Jungck, C. 30
K
Kasper, S. 20
Kato, M. 199Kellner, M. 41Kemmler, G. 1Khazaal, Y. 85Kinoshita, T. 199Kirsch, P. 196Knopf, U. 202Koch, K. S85Koch, M. S34Koethe, D. 82Konstantakopoulos, G. 295Kornhuber, J. 39, 292Koulouris, G.C. 295Krebs, M. 149Krieger, S. 275Kühn, K.U. 183Kühn, K-U. 58, 140Kuwilsky, A. 202
L
Lang, U.E. 38Lange-Asschenfeldt, C. 86Langer, S. 53Lasic, J.K. 203Latif, M.A. 257Laux, G. 121Leon, Jde. 93Leopold, K. 149Leufkens, H.G. 111Leuner, K. S17Leung, C-M. 47, 269Leweke, F.M. 82Lex, A. 257Libal, G. 72Linden, M. 77Linszen, D. 264Lis, S. 275Loh, M. S78López-Muñoz, F. 14Luborzewski, A. 170
M
Maier, W. 140, 183Marinis, T.De. 257Marksteiner, J. 129Martin-Latry, K. 116Masdrakis, V.G. 295Mauri, M.C. 89Medori, R. 257Mehler-Wex, C. 72Meisenzahl, E.M. S62Mier, D. 196Mittoux, A. 275Miyaoka, H. 201Modestin, J. 37Molina, V. 135, 157Möller, H.J. S62Möller, H-J. 53Monteiro, B.F. 169Morillas-Arques, P. 68Müller, D.J. 191Müller, W.E. S1, S17Müller-Oerlinghausen, B. 121Murafi, A. 58, 140
![Page 7: Content s III - Thieme · Content s III Phar macops ychiatr y 2007; 40 Issue 1 (January 2007) = Page 1 – 45 Issue 2 (March 2007) = Page 47 – 87](https://reader035.vdocuments.us/reader035/viewer/2022071101/5fdae29ed6608009004e5f82/html5/thumbnails/7.jpg)
Authors' Index VII
Pharmacopsychiatry 2007; 40
N
Nakamura, J. 9Neu, P. 170Neuhaus, A.H. 170Nijman, H.L. 25
O
Obermayer, K. S40Okugawa, G. 199Opgen-Rhein, C. 170Orrego, M.L. 93Oulis, P. 295Ozaki, N. 84
P
Palomo, T. 135, 157Pan, R-M. 93Papa, P. 89Pardo, A. 14Parwani, A.S. 294Pascau, J. 135Pietro, N.C. S27Pjrek, E. 20Plesnicar, A. 203Plesnicar, B.K. 203Praschak-Rieder, N. 20
R
Ramer, S.L. 103Rashid, J. 103Reig, S. 135Remschmidt, H. 128Rettenbacher, M.A. 1Ricard, C. 116Rico-Villademoros, F. 68Riederer, P. 121Rodriguez-Lopez, C.M. 68Rolf, S. 294Rolls, E.T. S78Rommelspacher, H. 191Ronshausen, S. 196Rossattini, M. 89Rothenhöfer, S. 72Rothermund, M. 140Rothermundt, M. 58Rubio, G. 14Rybakowski, J.K. 146
S
Sachs, G. 1Saleem, P.T. 257Sanches, M. 169Sánchez, J. 135Sanz, J. 135, 157Sarramea, F. 157Sawayama, E. 201Sawayama, T. 201Schaefer, M. 149Scheuerecker, J. S62Schlösser, R.G. S85Schmauß, M. 53
Schmitt, G.J. S62Schneiter, R. 37Schotte, K. 77Schubert, F. 64Schulze, D. 38Seamans, J.K. S27Seiringer, E. 129Shinkai, K. 9Signerski, J. 58, 140Singer, W. S54Souverein, P.C. 111Soyka, M. 291Sperling, W. 39Spigset, O. 107Stastny, J. 20Stein, D.J. 152Stolk, P. 111Stolker, J.J. 25Sträter, B. 58, 140, 183Supprian, T. 86Susce, M.T. 93
T
Takahashi, M. 201Takekita, Y. 199Tang, W-K. 47, 269Tanghøj, P. 275Täschner, B. 291Teijeiro, R. 257Teusch, L. 58, 140Theisen, F.M. 128Traber, R. 37Tretter, F. S1, S2
U
Uchida, R.R. 169Ueda, N. 9Uhlhaas, P.J. S54Ulrich, S. 121Ungvari, G.S. 47, 269
V
Valli, A. 89van Amelsvoort, T. 264Verdoux, H. 116Victorri-Vigneau, C. 43Vogels, T.P. S73Volonteri, L.S. 89
W
Wagner, G. S85Wakeno, M. 199Walker, R.H. 132Wang, R. 103Wedlund, P.J. 93Weig, W. 58, 140Weil, J.G. 111Welling, A. 58, 140Weng, Y-Z. 47, 269Wernicke, C. 191Westheide, J. 58, 140, 183Wewetzer, Ch. 72
Wilkosc, M. 146Willeit, M. 20Wiltfang, J. 39Windhager, E. 129Winkler, D. 20Winterer, G. S45Wittmann, M. 287Wolf, J. 129
X
Xiang, Y-T. 47, 269
Y
Yamashita, M. 199Yoshida, K. 84Yoshimura, R. 9
Z
Zernig, G. 121Zink, M. 202Zullino, D.F. 85